Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HRH2 | P25021 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | KDM5A | P29375 | 1/20 | 0.34 |
| ▸ | KDM5C | P41229 | 1/20 | 0.34 |
| ▸ | KDM5D | Q9BY66 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27811822 | 0.98 | CA12 (0.39) | CA12CA1CA9LMNAALDH1A1 | |
| Iodomethane SCHEMBL7516696 | 0.96 | CA12 (0.38) | CA12CA1CA9LMNAALDH1A1 | |
| SCHEMBL9129669 | 0.89 | KDM5A (0.39) | CA12CA1CA9LMNAALDH1A1 | |
| SCHEMBL35601 | 0.89 | ALDH1A1 (0.41) | LMNAALDH1A1HRH4CYP1A2HRH2 | |
| SCHEMBL18762850 | 0.84 | ALDH1A1 (0.48) | ALDH1A1HRH4CYP1A2HRH2TDP1 | |
| SCHEMBL293118 | 0.82 | CA12 (0.59) | CA12CA1CA9LMNAALDH1A1 | |
| SCHEMBL30620474 | 0.82 | DNM1 (0.58) | CA12CA1CA9ALDH1A1TSHR | |
| SCHEMBL28916907 | 0.81 | TDP1 (0.42) | LMNAALDH1A1HRH4CYP1A2HRH2 | |
| SCHEMBL5197804 | 0.80 | CA12 (0.52) | CA12CA1CA9LMNAALDH1A1 | |
| SCHEMBL13185664 | 0.80 | LMNA (0.47) | CA12CA1CA9LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105622538-A | One-pot high-yielding preparation of cetilistat | INST MATERIA MEDICA CAMS | 2016-06-01 | — | — | CN | claimed |
| EP-2480526-A1 | CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PGI2 RECEPTOR AGONISTS | Arena Pharmaceuticals, Inc. (US) | 2012-08-01 | — | — | EP | claimed |
| CN-102203064-A | Novel benzamides, their preparation and their use as medicaments | BOEHRINGER INGELHEIM INT | 2011-09-28 | — | — | CN | claimed |
| WO-2011037613-A1 | CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PGI2 RECEPTOR AGONISTS | ARENA PHARMACEUTICALS, INC. (US) | 2011-03-31 | — | — | WO | claimed |
| CN-1868543-A | Biodegradable high molecular gel medicine composition, its prepn. method and use thereof | UNIV SICHUAN (CN) | 2006-11-29 | — | — | CN | claimed |
| US-20060029662-A1 | Immunomodulatory compositions and methods of use thereof | GENZYME CORPORATION (US) | 2006-02-09 | — | — | US | claimed |
| EP-1171136-A2 | IMMUNOMODULATING COMPOSITION FOR USE ESPECIALLY IN THE TREATMENT OF INFLAMMATIONS, INFECTIONS AND SURGICAL ADHESIONS | GENZYME CORPORATION (US) | 2002-01-16 | — | — | EP | claimed |
| WO-2000059490-A2 | IMMUNOMODULATING COMPOSITION FOR USE ESPECIALLY IN THE TREATMENT OF INFLAMMATIONS, INFECTIONS AND SURGICAL ADHESIONS | GENZYME CORPORATION (US) | 2000-10-12 | — | — | WO | claimed |
| WO-2025099312-A1 | PEPTIDES AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF MULTIPLE SCLEROSIS | CELLERYS AG (CH) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553083-A1 | PEPTIDES AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF MULTIPLE SCLEROSIS | Cellerys AG (CH) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025085621-A1 | MULTIVALENT APTAMER-POLYMER CONJUGATES | VALITOR, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-4508078-A2 | HUMANIZED MULTIVALENT PROTEIN CONJUGATES | Valitor, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-4507730-A2 | PURIFIED MULTIVALENT PROTEIN-HYALURONIC ACID POLYMER CONJUGATES | Valitor, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-119213019-A | Humanized multivalent protein conjugates | 瓦利托尔有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2006036984-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| US-20060067983-A1 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20040180871-A1 | Anti-inflammatory compositions and methods | GENZYME CORPORATION | 2004-09-16 | — | — | US | disclosed |
| WO-2004063181-A1 | UREA DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | GENZYME CORPORATION (US) | 2004-07-29 | — | — | WO | disclosed |
| EP-1171136-A2 | IMMUNOMODULATING COMPOSITION FOR USE ESPECIALLY IN THE TREATMENT OF INFLAMMATIONS, INFECTIONS AND SURGICAL ADHESIONS | GENZYME CORPORATION (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000059490-A2 | IMMUNOMODULATING COMPOSITION FOR USE ESPECIALLY IN THE TREATMENT OF INFLAMMATIONS, INFECTIONS AND SURGICAL ADHESIONS | GENZYME CORPORATION (US) | 2000-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060029662-A1 | Immunomodulatory compositions and methods of use thereof | CD47, MSR1, CD14 | CA12 1287/4885CA1 2368/4885CA9 2870/4885 |
| US-20040180871-A1 | Anti-inflammatory compositions and methods | CD4, LCP2, IL6 | CA12 3804/4885CA1 2776/4885CA9 3933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.